Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Sport Concussion Assessment - Test Stability and Effect of Concussion
23. September 2019 aktualisiert von: ElMindA Ltd
Mild traumatic brain injury (mTBI), also known as concussion, occurs commonly in sport. Despite ongoing research, there is no highly sensitive clinical test for cognitive function. This makes the clinical diagnosis of concussion particularly difficult as the clinical presentation of concussion is highly variable with symptoms often evolving over time. Given the variability in concussion presentations, there is no single test that can diagnose a concussion. Current recommendations are that sports medicine providers apply a multifaceted concussion assessment battery that combines subjective symptoms, motor control and cognitive assessment.
This investigation is designed to evaluate the clinical utility of ElMindA's BNA scores in detecting and managing concussive injuries. This study will establish the reliability of BNA™ scores over clinically relevant assessment intervals and investigate the effect of SRC and sub-concussive head impacts on BNA scores.
Studienübersicht
Status
Abgeschlossen
Bedingungen
Studientyp
Beobachtungs
Einschreibung (Tatsächlich)
109
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
Michigan
-
Ann Arbor, Michigan, Vereinigte Staaten, 48105
- Michigan NeuroSport Concussion Program
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
14 Jahre bis 26 Jahre (Kind, Erwachsene)
Akzeptiert gesunde Freiwillige
Nein
Studienberechtigte Geschlechter
Alle
Probenahmeverfahren
Nicht-Wahrscheinlichkeitsprobe
Studienpopulation
Phase 1: gender-balanced groups of 30 healthy high school (14-17 years old) and 30 healthy college aged (18-26 years old) individuals who participate in non-contact sports Phase 2a: 30 high school and/or collegiate athletes aged 14-26 years with concussion and 30 matched control athletes.
Phase 2b: at least 30 high school and/or collegiate contact sport athletes aged 14-26 years whose head impacts are monitored during games and practices.
Beschreibung
Phase 1:
Inclusion Criteria:
- Aged 14-26 years
- Enrolled in a recognized high school or college
- Willingness to participate and able to give informed assent (child) and/or consent (parent for minors or adult 18+ years of age for self)
- Currently participate in a non-contact sport.
- Member of an organized athletic team or regularly train for and participate in independent athletic contests during at least one sports season.
- Right handed subject
Exclusion Criteria:
- Currently participate in a contact sport.
- Bald or has dread locks/long and thick hair.
- Any diagnosed psychiatric disorder
- History of CNS injury or disease
- Any neuropsychological disorders
- History of learning disability.
- History of any medication affecting CNS.
- Active head lice infection, open scalp wound, deafness or/and blindness.
- Sustained a diagnosed concussion within the previous 6 months
Phase 2a:
Inclusion Criteria:
- Aged 14-26 years.
- For Arm 1: Within 1 week post-concussion (sports-related).
- For Arm 1: Currently symptomatic
- Willingness to participate and able to give informed assent (child) and/or consent (parent for minors or adult 18+ years of age for self).
- Member of an organized athletic team or regularly train.
- Enrolled in a high school or college.
Exclusion Criteria:
- Bald or has dread locks/long and thick hair.
- Current or history of ADHD.
- Active head lice infection, open scalp wound, deafness or/and blindness.
- Sustained a concussion within the past 6 months.
- Current or history of moderate or severe TBI, any brain injury with positive neuroimaging findings, or brain surgery.
Phase 2b:
Inclusion Criteria:
- Aged 14-26 years.
- Willingness to participate and able to give informed assent (child) and/or consent (parent for minors or adult 18+ years of age for self).
- Member of a contact sport team which carries out head impact monitoring over the course of the playing season.
- Enrolled in a high school or college.
Exclusion Criteria:
- Bald or has dread locks/long and thick hair.
- Current or history of ADHD.
- Active head lice infection, open scalp wound, deafness or/and blindness.
- Sustained a concussion within the past 6 months.
- Current or history of moderate or severe TBI, any brain injury with positive neuroimaging findings, or brain surgery.
- Any diagnosed psychiatric disorder.
- History of CNS injury or disease
- Any neuropsychological disorders.
- History of learning disability.
- History of any medication affecting CNS.
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Beobachtungsmodelle: Kohorte
- Zeitperspektiven: Interessent
Kohorten und Interventionen
Gruppe / Kohorte |
|---|
|
Phase I - Normative
Athletes who does not participate in contact sport with no recent concussion
|
|
Phase IIa - Concussed
Athletes with recent concussion
|
|
Phase IIa - Control
Athletes with no recent concussion
|
|
Phase IIb - Athletes
Athletes with no recent concussion
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
|---|---|
|
Change of Brain Network Activation(BNA™)Scores
Zeitfenster: P.I - days 0 , 7, 42, 365 ; P.IIa - 1 week of injury, 48 hours of symptom resolution, 48 hours of clearance to sport, 1 month after symptom resolution; P.IIb - baseline, mid season, 30 days of completion of the season
|
P.I - days 0 , 7, 42, 365 ; P.IIa - 1 week of injury, 48 hours of symptom resolution, 48 hours of clearance to sport, 1 month after symptom resolution; P.IIb - baseline, mid season, 30 days of completion of the season
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
|---|---|
|
Correlation Of The Change In BNA™ Scores To Clinical Diagnstic
Zeitfenster: P.I - days 0 , 7, 42, 365 ; P.IIa - 1 week of injury, 48 hours of symptom resolution, 48 hours of clearance to sport, 1 month after symptom resolution; P.IIb - baseline, mid season, 30 days of completion of the season
|
P.I - days 0 , 7, 42, 365 ; P.IIa - 1 week of injury, 48 hours of symptom resolution, 48 hours of clearance to sport, 1 month after symptom resolution; P.IIb - baseline, mid season, 30 days of completion of the season
|
|
Correlation Of The Change In BNA™ Scores To Neurocognitive Tests Scroes
Zeitfenster: P.IIa - 1 week of injury, 48 hours of symptom resolution, 48 hours of clearance to sport, 1 month after symptom resolution; P.IIb - baseline, mid season, 30 days of completion of the season
|
P.IIa - 1 week of injury, 48 hours of symptom resolution, 48 hours of clearance to sport, 1 month after symptom resolution; P.IIb - baseline, mid season, 30 days of completion of the season
|
|
Correlation Of The Change In BNA™ Scores To Reaction Time Scores
Zeitfenster: P.IIa - 1 week of injury, 48 hours of symptom resolution, 48 hours of clearance to sport, 1 month after symptom resolution; P.IIb - baseline, mid season, 30 days of completion of the season
|
P.IIa - 1 week of injury, 48 hours of symptom resolution, 48 hours of clearance to sport, 1 month after symptom resolution; P.IIb - baseline, mid season, 30 days of completion of the season
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn
1. Februar 2012
Primärer Abschluss (Tatsächlich)
1. Dezember 2015
Studienabschluss (Tatsächlich)
1. Dezember 2015
Studienanmeldedaten
Zuerst eingereicht
12. Februar 2012
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
14. Februar 2012
Zuerst gepostet (Schätzen)
17. Februar 2012
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
25. September 2019
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
23. September 2019
Zuletzt verifiziert
1. September 2019
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- ELM-03
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Nein
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Nein
Produkt, das in den USA hergestellt und aus den USA exportiert wird
Nein
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Leichte traumatische Hirnverletzung
-
Kessler FoundationInstituto Vocacional Enrique Díaz de León A.C., Guadalajara, MexicoRekrutierungTBI (Traumatic Brain Injury) oder MS (Multiple Sklerose)Vereinigte Staaten, Spanien